Science Explorer Interactive view Map
Nonprofit · Heidelberg · Australia

Ludwig Cancer Research

In research, Ludwig Cancer Research stands highest in Life Sciences (#2,445 of 14,347 worldwide), Medicine (#4,129 of 17,978 worldwide) and Health Sciences (#5,599 of 20,462 worldwide), over all time. Relative to its size it is most specialised in Oncology, Immunology and Immunology and Microbiology — Oncology is 13.1× its share of world research.

ludwigcancerresearch.orgROR OpenAlex
World rank, all time
#5,404
of 42,892
Rank in Australia
#121
of 656
Research works
801
▼ 96% vs 2013–17
Citations
54k
67.6 per fractional work
Top-10% rate
20.3%
record average 16.5%
Open access
30%
world 28%

What is Ludwig Cancer Research known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #2,445 of 14,347 29.0%388
MedicineField #4,129 of 17,978 32.2%339
Health SciencesDomain #5,599 of 20,462 32.2%344
Biochemistry, Genetics and Molecular BiologyField #3,744 of 7,814 28.5%271
Molecular BiologySubfield #2,391 of 4,961 28.0%180

Each strip is that field’s whole ranked pool, with the notch where Ludwig Cancer Research sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Ludwig Cancer Research specialise in?

Where its research is concentrated relative to its size: Oncology takes 13.1× the share of its output that it takes of world research.

  1. OncologySubfield · 115.4 works13×
  2. ImmunologySubfield · 87.0 works13×
  3. Immunology and MicrobiologyField · 91.1 works9.3×
  4. Radiology, Nuclear Medicine and ImagingSubfield · 53.8 works7.0×
  5. SpectroscopySubfield · 26.2 works7.0×
  6. Cancer ResearchSubfield · 24.6 works6.7×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Ludwig Cancer Research?

Ranked on the composite score, Antony W. Burgess, George Morstyn and Jonathan Cebon lead among researchers whose main affiliation is Ludwig Cancer Research.

  1. 1 Antony W. Burgess Australia · #53,277 worldwide 537 citations · 45 works
  2. 2 George Morstyn Australia · #66,294 worldwide 287 citations · 34 works
  3. 3 Jonathan Cebon Australia · #66,311 worldwide 498 citations · 84 works
  4. 4 Matthias Ernst Australia · #116,908 worldwide 234 citations · 45 works
  5. 5 Eugene Maraskovsky Australia · #178,428 worldwide 148 citations · 31 works
  6. 6 Joan K. Heath Australia · #192,605 worldwide 185 citations · 30 works
  7. 7 Graham J. Lieschke Australia · #199,735 worldwide 150 citations · 27 works
  8. 8 Andrew F. Wilks Australia · #225,306 worldwide 159 citations · 20 works
  9. 9 Andrew C. Oates Australia · #270,666 worldwide 150 citations · 22 works
  10. 10 Ashley R. Dunn Australia · #324,709 worldwide 175 citations · 20 works
All ranked researchers at Ludwig Cancer Research

Which keywords describe research at Ludwig Cancer Research?

By fractional works in all years, weighted toward what it does more of than the world: Cancer, Inflammation, Glycosylation, Chemotherapy, Cancer Therapy, Tumor Microenvironment, Immune Response and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer109▲ 9.7×41 topics
  2. Inflammation97▲ 5.1×51 topics
  3. Glycosylation51▲ 29×3 topics
  4. Chemotherapy48▲ 8.4×23 topics
  5. Cancer Therapy45▲ 8.8×16 topics
  6. Tumor Microenvironment43▲ 15×8 topics
  7. Immune Response40▲ 8.1×18 topics
  8. Immunotherapy39▲ 7.4×18 topics
  9. Monoclonal Antibodies35▲ 30×3 topics
  10. Therapeutic Antibodies35▲ 34×2 topics
  11. Innate Immunity31▲ 11×10 topics
  12. Immunity31▲ 11×8 topics
  13. Antibody Engineering31▲ 38×1 topic
  14. Fc Receptors31▲ 38×1 topic
  15. Cancer Immunotherapy30▲ 27×3 topics
  16. Angiogenesis27▲ 8.1×13 topics
  17. Antigen Presentation27▲ 33×2 topics
  18. IL-625▲ 96×1 topic
  19. STAT325▲ 96×1 topic
  20. Targeted Therapy25▲ 15×5 topics
  21. Transcriptional Regulation25▲ 12×9 topics
  22. Metastasis23▲ 8.4×12 topics
  23. Breast Cancer22▲ 9.8×9 topics
  24. Mass Spectrometry22▲ 13×3 topics
  25. Genetic Mutations21▲ 5.1×14 topics
  26. Dendritic Cells21▲ 23×2 topics
  27. Tumor Antigen21▲ 32×1 topic
  28. Vaccine Adjuvants21▲ 32×1 topic
  29. Pattern Recognition Receptors21▲ 18×2 topics
  30. Receptor tyrosine kinases19▲ 55×2 topics
  31. Gene Therapy19▲ 9.1×6 topics
  32. Proteomics19▲ 20×3 topics
  33. Monoclonal Antibody19▲ 34×2 topics
  34. Therapeutics18▲ 16×2 topics
  35. Toll-like Receptors18▲ 13×4 topics
  36. Pathogen Recognition18▲ 25×2 topics
  37. Autoimmunity17▲ 10×4 topics
  38. Metastatic17▲ 33×2 topics
  39. Cytokine-Mediated Link17▲ 30×1 topic
  40. Innate Antiviral Responses17▲ 30×1 topic

Which research topics does Ludwig Cancer Research publish most on?

By volume in 2022–2025: Immunotherapy and Immune Responses, Cancer Mechanisms and Therapy, Cancer-related gene regulation and Peptidase Inhibition and Analysis.

Immunotherapy and Immune…0Immunotherapy and Immune Responses: 0 fractional worksCancer Mechanisms and Th…0Cancer Mechanisms and Therapy: 0 fractional worksCancer-related gene regulation: 0 fractional worksPeptidase Inhibition and Analysis: 0 fractional worksMetabolism, Diabetes, an…0Metabolism, Diabetes, and Cancer: 0 fractional worksImmune Response and Inflammation: 0 fractional worksGrowth Hormone and Insulin-like Growth Factors: 0 fractional worksImmune responses and vac…0Immune responses and vaccinations: 0 fractional worksCancer Risks and Factors: 0 fractional worksCancer Research and Treatments: 0 fractional works
ImmunologyPathology and Forensic MedicineMolecular BiologyOncology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immunotherapy and Immune Responses Immunology 0 works
  2. 2 Cancer Mechanisms and Therapy Pathology and Forensic Medicine 0 works
  3. 3 Cancer-related gene regulation Molecular Biology 0 works
  4. 4 Peptidase Inhibition and Analysis Oncology 0 works
  5. 5 Metabolism, Diabetes, and Cancer Molecular Biology 0 works
  6. 6 Immune Response and Inflammation Immunology 0 works
  7. 7 Growth Hormone and Insulin-like Growth Factors Endocrinology, Diabetes and Metabolism 0 works
  8. 8 Immune responses and vaccinations Immunology 0 works
  9. 9 Cancer Risks and Factors Oncology 0 works
  10. 10 Cancer Research and Treatments Biotechnology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.9%not open70.1%

World: 28% of research is openly available.

with international co-authors29.1%domestic only70.9%

World: 19% is written across borders.

How has Ludwig Cancer Research's research output changed?

Output in 2018–2022 was 96% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Heidelberg

All research institutions in Heidelberg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.